Literature DB >> 3523039

Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.

F J Guillén, J Ferrara, W W Hancock, D Messadi, E Fonferko, S J Burakoff, G F Murphy.   

Abstract

We studied the morphologic and immunophenotypic characteristics of inflammatory infiltrates in the skin of mice with acute graft-versus-host disease induced by bone marrow transplantation between strains differing only in minor histocompatibility antigens. The strain combinations employed (B10.Br - greater than CBA) have been shown to produce a lethal graft-versus-host disease with clinical severity proportional to the number of T lymphocytes added to the donor marrow inoculum. Transplant recipients developed pronounced clinical signs of graft-versus-host disease, including copious diarrhea and weight loss, and histologic alterations in skin strikingly similar to this disease in humans. Our findings indicate that the preponderant mononuclear cell in lesional skin from these animals has phenotypic characteristics of a natural killer cell. This cell was often found in apposition with necrotic epidermal cells. The origin, function, and potential relevance of natural killer cells in lesion formation in this experimental model are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523039

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  14 in total

1.  Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.

Authors:  L Q Gao; G L Asherson; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

Review 2.  Bone marrow transplantation: the genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease.

Authors:  J Ferrara; P Mauch; G Murphy; S J Burakoff
Journal:  Surv Immunol Res       Date:  1985

Review 3.  Current thoughts on the pathogenesis of graft versus host disease.

Authors:  A L Appleton; L Sviland
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

4.  Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome.

Authors:  D J Ringler; W W Hancock; N W King; N L Letvin; M D Daniel; R C Desrosiers; G F Murphy
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

5.  Hairless micropig skin. A novel model for studies of cutaneous biology.

Authors:  R M Lavker; G Dong; P S Zheng; G F Murphy
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

6.  Cellular blebbing in superficial colonic epithelial cells occurring with murine graft-versus-host disease.

Authors:  M L Eigenbrodt; J S Kneitz; D L Thiele; E H Eigenbrodt
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.

Authors:  M Takata; T Imai; T Hirone
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

8.  Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.

Authors:  K Varkila
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

9.  Kinetics of gene expression in murine cutaneous graft-versus-host disease.

Authors:  Philip B Sugerman; Sara B Faber; Lucy M Willis; Aleksandra Petrovic; George F Murphy; Jacques Pappo; David Silberstein; Marcel R M van den Brink
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 10.  Natural killer cell-endothelial cell interactions in xenotransplantation.

Authors:  J R Dawson; A C Vidal; A M Malyguine
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.